Royal Philips to acquire Malvern medical device developer BioTelemetry for $2.8B
December 18, 2020 at 08:35 AM EST
The $72 per share offer price represents a 16.5% premium to BioTelemetry’s Dec. 17 closing price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|